エピソード

  • MRNA Today - Aug 13: Bank of America Sells Shares

    MRNA Today - Aug 13: Bank of America Sells Shares
    2026/08/13
    Hey there! It’s Joey here, your friendly neighborhood investor, breaking down what went down with Moderna today. So, MRNA had a pretty chill day, just barely moved up, closing at 64 bucks and change. Not a crazy jump, but hey, at least it’s not in the red!

    Now, let’s get into what’s going on. The big news today? Bank of America decided to sell off a hefty chunk of Moderna shares—like, almost 400,000 of them! Yeah, that one stung a bit for the stock. When big players like that start selling, it can freak people out, and some folks hit the sell button fast. So, there was definitely some nervous energy in the air.

    On the flip side, we also heard from Capital World Investors. They filed a report saying they have a 5.6% stake in Moderna. So, it’s not all doom and gloom. It shows there’s still interest from some heavy hitters. But with the Bank of America news, it kind of overshadowed that positive vibe.

    And here’s something else that caught my eye. The CDC is keeping quiet about a report on COVID-19 vaccine effectiveness. That’s kind of a big deal, especially with all the chatter around vaccines and health stuff lately. Also, Moderna’s got some mRNA bird flu vaccine in late-stage testing, which could be a big step forward for them. So, they’re still in the game, just dealing with some market drama.

    To wrap it up, Moderna had a slow day, mostly influenced by that big sell-off from Bank of America. But there’s still some positive movement in the background with other investors and ongoing projects. Just remember, this info is for your entertainment, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • MRNA Today - Aug 12: FDA Approves mRNA Flu Vaccine

    MRNA Today - Aug 12: FDA Approves mRNA Flu Vaccine
    2026/08/12
    Hey there! It’s Joey, your friendly stock guy, breaking down the day for ya. Today we're talking about Moderna, and it was a green day for them—up about 2%!

    So, here’s what went down. Moderna had a pretty solid day, gaining some traction after the FDA gave the thumbs up for their first mRNA flu vaccine. That news definitely got some folks excited. But even with that good news, the stock didn’t go wild. It kinda felt like it was just cruising along, right? Like, yeah, it got a boost, but it wasn’t the kind of explosion you might expect from a big announcement.

    Now, why the mixed vibes? Well, while the FDA approval is huge, it's also part of a bigger picture. The market's been pretty jittery lately, with other news swirling around. For instance, there was chatter about the CDC not publishing a report on COVID-19 vaccine effectiveness. That’s a bit of a head-scratcher and could leave people feeling uncertain. Plus, there was a report about a former pharmacy president getting sentenced for a big kickback scheme. Yikes! So, yeah, the context around the stock wasn’t all sunshine and rainbows today.

    On top of that, there’s been some selling pressure, too. Bank of America sold a chunk of shares, which might have made some investors a bit nervous. When big players like that start unloading, it can make people hit the sell button fast, even if the news is good.

    Looking ahead, there's a lot of buzz around Moderna's mRNA technology, especially with that bird flu vaccine hitting late-stage testing. It’s like Moderna's trying to be the go-to player for all things mRNA, and that could open up some exciting doors down the line.

    So, to wrap it up, Moderna had a decent day, boosted by the FDA’s green light for their flu vaccine, but the market’s been a bit shaky with other news making waves. Just remember, this is all for info and fun, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • MRNA Today - Aug 11: Flu Shot News Moves Stock

    MRNA Today - Aug 11: Flu Shot News Moves Stock
    2026/08/11
    Hey there! It’s Joey, your friendly investor buddy, here to break down what went down with Moderna today. So, MRNA was in the green today, up about one percent. Not a huge jump, but hey, we’ll take it!

    So, here’s the scoop. Moderna had a pretty chill day in the market, with volume hanging right around average. But the buzz? It was all about their flu shot news. Yeah, people were talking about how they’re stepping up their game in the flu vaccine department. It seems like folks are getting a bit more excited about the potential there, which gave the stock a little boost.

    Now, why the excitement? Well, it looks like there's a growing interest in flu shots, especially as we head into the fall season. With COVID still lingering, people are more aware of their health and looking for ways to stay protected. Moderna’s flu shot is catching some attention, and that’s likely why people decided to hit the buy button instead of selling. It’s all about that seasonal vibe, you know?

    Oh, and here’s a tidbit: there’s chatter about how Moderna is still on the sidelines with a few things, but if they hit certain targets, they might just change their game. So, keep an eye on that. It’s like waiting for that perfect moment in a video game to strike!

    To wrap it all up, it was a decent day for Moderna, thanks to that flu shot news. Just remember, I’m here to keep you informed and entertained, but this isn’t financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • MRNA Today - Aug 10: Small Gains Amid Mixed News

    MRNA Today - Aug 10: Small Gains Amid Mixed News
    2026/08/10
    Hey there! It’s Joey here, your friendly investor buddy. I’ve been in the game for a while, and today we’re talking about Moderna, ticker MRNA. It was a bit of a mixed bag today, with the stock barely moving—up just a smidge, like 0.4%. So, not a wild ride, but hey, we’ll take it.

    So, here’s what went down. Moderna had a pretty quiet day overall. The volume was right in line with what we usually see, so nothing too dramatic there. It kinda felt like just another day in the office. I mean, it did flirt with the $60 mark, but it didn’t stick. People seemed chill, not too eager to push the stock one way or the other.

    Now, let’s chat about why that might be. There’s been a lot of buzz about Moderna’s pipeline lately, especially with the news about their Ebola trial getting the green light in Canada. That’s a big deal and could redefine what the company’s up to. But, on the flip side, there’s also some chatter about the CDC not publishing a report on COVID-19 vaccine effectiveness. That’s got some folks scratching their heads about the vaccine's future. And then there’s this other story about a former pharmacy president getting hit with a massive kickback scheme. Yeah, that one stung for the pharma world. So, with all this mixed news, it seems like investors are just hanging tight, waiting to see how things shake out.

    One quick thing to keep in mind is that Contravisory Investment Management just scooped up some shares of Moderna. That could mean they see potential here, but who knows? People have different takes on this stock, and it’s always a mixed bag in the market.

    Alright, that’s a wrap for today! Just remember, I’m here sharing info and having fun with this stuff, not giving financial advice. So, keep your chin up and happy investing! Catch you next time!
    続きを読む 一部表示
    2 分
  • MRNA Today - Aug 09: FDA Flu Vaccine Approval

    MRNA Today - Aug 09: FDA Flu Vaccine Approval
    2026/08/09
    Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in the game for a while, and today we’re chatting about Moderna, ticker MRNA. Spoiler alert: it was a green day for them, up almost 10%! Nice little jump.

    So, what went down? Moderna's stock had a solid day, shooting up thanks to some FDA news. They just snagged approval for their flu vaccine, which is a pretty big deal. Everyone's buzzing about it, and that excitement definitely translated to the stock price. People are feeling good about the potential there.

    Now, why the hype? Well, the FDA giving the thumbs-up means Moderna's flu shot is officially ready for action. It’s like getting a gold star, you know? Plus, there’s chatter about how this could boost their bottom line, especially since they’re also working on other mRNA vaccines. It’s all about that positive momentum. On top of that, there’s some movement with stock sales from their CEO, which might have spiced things up a little, but honestly, that’s just typical stock market stuff.

    Oh, and here’s a quick heads-up: while the flu vaccine approval is great, there's still some uncertainty. They’re waiting on recommendations from the CDC, so that’ll be something to keep an eye on.

    To wrap it up, Moderna had a great day with that FDA approval giving them a nice boost. It’s always exciting to see how these developments play out in the market. Just remember, I’m here to share the info and keep it fun, not to give any financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • MRNA Today - Aug 08: FDA Clearance, Stock Slides

    MRNA Today - Aug 08: FDA Clearance, Stock Slides
    2026/08/08
    Hey there! It’s Joey here, your friendly investor buddy. I’ve been in the game for years, and today we’re talking about Moderna. So, it was a red day for MRNA, with the stock sliding down about 9.9%. Ouch, right?

    So, what happened? Well, despite the excitement around Moderna getting FDA clearance for its flu vaccine, the stock didn’t really catch fire. It actually dropped. I know, kinda wild. You’d think good news would send it soaring, but nope. Instead, it got smoked.

    Now, why’d it slide? A few reasons floating around. First off, even with the FDA nod, there’s some skepticism in the market. Investors are a bit on edge about how well the flu vaccine will perform and if it can really boost sales. Plus, there’s chatter about stock sales from the CEO under a Rule 10b5-1 plan, which kinda raised eyebrows. When the boss is cashing in, people start to wonder, you know? It’s like, “Is he seeing something we’re not?” And that uncertainty got folks hitting the sell button pretty fast.

    Oh, and there’s this whole “buy the dip” buzz going on, but honestly, it didn’t help today. A lot of people just seem to be waiting to see how this all plays out.

    One quick thing to keep in mind is that Moderna’s still got its hands in the game with mRNA tech, and they’re working on a bunch of stuff beyond just COVID and flu vaccines. So, they’re not out of the race yet.

    Alright, that’s a wrap for today! Just remember, this is all for fun and info, not financial advice. Stay chill, and catch you later!
    続きを読む 一部表示
    1 分
  • MRNA Today - Aug 07: Major FDA Approval

    MRNA Today - Aug 07: Major FDA Approval
    2026/08/07
    Hey there! It’s Joey here, your friendly neighborhood investor, and I’m breaking down what went down with Moderna today. So, MRNA had a bit of a rollercoaster ride. It popped up around 4% early on but ended the day in the red. Yeah, that one stung.

    So, what happened? Well, Moderna snagged a major FDA approval for its flu vaccine, which is usually a big win. You'd think that would send the stock soaring, right? But nope, it didn’t quite play out that way. The stock started strong, but then people started hitting the sell button for some reason. It’s like they got cold feet after the initial excitement.

    Now, why did that happen? Some folks are saying it’s a classic case of buy the rumor, sell the news. The hype was there before the approval, but when the actual news dropped, it didn’t have the legs to keep running. Plus, there’s chatter about how Moderna's been cutting costs and focusing on its pipeline. That sounds smart, but it might have made investors a bit jittery about what’s coming next.

    And get this, even with the FDA win, some analysts are saying the stock’s flashing a “buy the dip” signal. So, it’s like a mixed bag of feelings. People are excited about the future but also a bit cautious about how the company’s been managing its resources.

    One quick thing to keep an eye on: Moderna’s Q2 earnings call highlighted some significant cost cuts and pipeline milestones. That could mean they’re getting serious about their strategy moving forward.

    So, to wrap it all up, Moderna had a wild day. Major FDA approval but still ended up slipping. It’s a reminder that good news doesn’t always equal good vibes in the market. Just keep this info in your back pocket—no financial advice here, just sharing the scoop. Catch you later!
    続きを読む 一部表示
    2 分
  • MRNA Today - Aug 06: Flu Vaccine Approval Sparks Interest

    MRNA Today - Aug 06: Flu Vaccine Approval Sparks Interest
    2026/08/06
    Hey there! It’s Joey, your friendly neighborhood investor, here to break down what went down today with Moderna, or MRNA as we like to call it. So, today was a green day for them, up just a little bit at 0.42%.

    Now, let’s get into the nitty-gritty. The stock had a nice little bump thanks to some exciting news. Moderna just got the green light for its flu vaccine, and that’s got people feeling pretty optimistic about what this means for the future. You know, after all the pandemic craziness, a solid flu vaccine feels like a step towards a more normal world.

    But wait, there’s more! They also dropped some promising data on a hantavirus vaccine. That caught the eye of analysts, leading to some chatter about potential price targets getting raised. It’s like a double whammy of good news that gave investors a reason to hit that buy button.

    So, why did the stock react this way? Well, the flu vaccine approval is a big deal. It signals that Moderna's not just a one-hit-wonder with COVID stuff. They’re showing they can play in the broader vaccine game. Plus, the hantavirus news adds a little more fuel to the fire. Analysts are feeling more confident, and that’s always a good sign for stock movement.

    And just a quick heads-up—Moderna had their Q2 earnings call today. These earnings calls can sometimes stir the pot, so definitely keep an eye on how the company feels about its future plans and any new projects they might be cooking up.

    Alright, that’s the scoop for today! It’s always fun to see a stock like Moderna shake things up a bit. Just remember, I’m here to give you the info, not to tell you what to do with your money. So, keep it chill and do your own research. Catch you later!
    続きを読む 一部表示
    2 分